日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial

奥拉帕尼、度伐利尤单抗和环磷酰胺联合预后血液特征治疗铂敏感卵巢癌:一项随机 II 期 SOLACE2 试验

Chee Khoon Lee ,Apriliana E R Kartikasari # ,Nirashaa T Bound # ,Katherine E Francis ,Kristy Shield-Artin ,Justin Bedo ,Ksenija Nesic ,Katrina Diamante ,Rachel L O'Connell ,Mutsa Madondo ,Momodou Cox ,Claire Davies ,Cyril Deceneux ,Georgia Goodchild ,Andrew Jarratt ,Emily Cassar ,Hina Amer ,U G Imalki U Kariyawasam ,Yeh Chen Lee ,Janine Lombard ,Sally Baron-Hay ,Yoland Antill ,Catherine Shannon ,Sudarshan Selva-Nayagam ,Philip Beale ,Danka Zebic ,Sandy Simon ,Anneliese Linaker ,Michael A Quinn ,Anthony T Papenfuss ,Matthew J Wakefield ,Cassandra J Vandenberg ,Michael Friedlander # ,Clare L Scott # ,Magdalena Plebanski #

Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform.

利用 iRS 平台测量 α-突触核蛋白错误折叠作为帕金森病液体生物标志物

Schuler Martin, Gerwert Grischa, Mann Marvin, Woitzik Nathalie, Langenhoff Lennart, Hubert Diana, Duman Deniz, Höveler Adrian, Galkowski Sandy, Simon Jonas, Denz Robin, Weber Sandrina, Kwon Eun-Hae, Wanka Robin, Kötting Carsten, Güldenhaupt Jörn, Beyer Léon, Tönges Lars, Mollenhauer Brit, Gerwert Klaus

Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG

通过 FACT 复合物和组蛋白去乙酰化酶双重靶向表观基因组是治疗 DIPG 的有效策略

Anahid Ehteda, Sandy Simon, Laura Franshaw, Federico M Giorgi, Jie Liu, Swapna Joshi, Jourdin R C Rouaen, Chi Nam Ignatius Pang, Ruby Pandher, Chelsea Mayoh, Yujie Tang, Aaminah Khan, Caitlin Ung, Ornella Tolhurst, Anne Kankean, Elisha Hayden, Rebecca Lehmann, Sylvie Shen, Anjana Gopalakrishnan, Pet